Outcomes evaluated were local recurrence, distant recurrence, and survival.
结果采用局部复发，远处复发和生存率来评估。
Outcomes evaluated included local recurrence, distant recurrence, and cancer specific survival.
评价结果包括局部复发，远处复发，肿瘤特异性生存率。
Conclusion Among women living at least 1 year after a breast cancer diagnosis, aspirin use was associated with a decreased risk of distant recurrence and breast cancer death.
结论在乳腺癌诊断后生存期至少1年的女性中，使用阿司匹林与乳腺癌远处复发和死亡风险降低密切相关。
应用推荐